At a glance
ClinicalIndex Comparison RecordN/ACompleted· 106 enrolled
Drug / intervention
Neurostimulator Precisiondevice
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
Two-years Follow-up of Post-spinal Implantable Neurostimulator PRECISION®
In Brief
An observational study evaluating Neurostimulator Precision for Chronic Refractory Neuropathic Pain and Ischemic Peripheral Pain. Completed, enrolled 106 participants across 1 site.
Detailed Summary
Assessing the long-term efficacy, complications, revision rates and final explantation of the device
Study Details
Study Typeobservational
Allocation--
Masking--
Primary Purpose--
CountriesFrance
CollaboratorsBoston Scientific Corporation
Timeline
N/ACompletedFinished
2014201520162017201820192020202120222023202420252026
Enrollment StartDec 2013
First PostedAug 2014
Primary CompletionDec 2017
TodayJul 2026
First PostedAug 5, 2014
Enrollment StartDec 1, 2013
Primary CompletionDec 1, 2017
TodayJul 2, 2026
Enrollment to primary: 4 yearsPosted 11.9 years ago
Interventions
Neurostimulator Precisiondevice
All patients included must have been implanted with the neurostimulator Precision